Colinz Laboratories quarterly results and financials

Colinz Laboratories (BSE 531210)₹70.00+1.46%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Colinz Laboratories reported sales of ₹1.23 Cr, down 21.2% from Jun 2025, and net profit of ₹2.41 Cr, up 1,753.8% year on year. For the year to Mar 2026, sales were ₹6.13 Cr and net profit ₹0.52 Cr.

Sales (Jun 2026): ₹1.23 Cr
Net profit (Jun 2026): ₹2.41 Cr
Sales (FY Mar 2026): ₹6.13 Cr
Net profit (FY Mar 2026): ₹0.52 Cr
EPS (Jun 2026): ₹9.50
Borrowings (Mar 2026): ₹0.38 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Colinz Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Colinz Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1.78	1.70	1.62	1.74	1.85	1.46	1.44	1.56	1.38	1.42	1.74	1.23
Expenses	1.68	1.58	1.52	1.60	1.70	1.41	1.36	1.45	1.32	1.34	1.67	1.19
Operating Profit	0.11	0.13	0.11	0.15	0.16	0.06	0.09	0.12	0.07	0.09	0.08	0.05
OPM %	6.7%	8.2%	7.4%	9.2%	9.1%	4.8%	6.9%	8.3%	5.8%	7.0%	5.1%	4.9%
Other Income	0.09	0.06	0.12	0.08	0.09	0.09	0.09	0.09	0.17	0.09	0.18	2.90
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.05	0.05	0.05	0.05
Profit before tax	0.15	0.16	0.18	0.20	0.20	0.12	0.12	0.15	0.18	0.12	0.20	2.89
Tax %	25.0%	26.7%	31.6%	26.3%	23.8%	45.5%	−23.1%	25.0%	26.3%	30.8%	19.0%	17.2%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.28
Net Profit	0.13	0.12	0.15	0.15	0.17	0.06	0.16	0.13	0.15	0.09	0.18	2.41
EPS (Rs)	0.47	0.43	0.55	0.55	0.63	0.19	0.59	0.47	0.55	0.31	0.66	9.50

Colinz Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Colinz Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	8.07	8.03	7.80	7.57	7.51	6.14	6.95	7.13	7.01	6.51	6.13	5.77
Expenses	7.67	7.67	7.50	7.26	7.24	5.84	6.40	6.53	6.51	6.06	5.74	5.52
Operating Profit	0.44	0.40	0.34	0.34	0.30	0.33	0.58	0.62	0.53	0.48	0.41	0.29
OPM %	5.6%	5.1%	4.5%	4.6%	4.1%	5.5%	8.5%	8.8%	7.7%	7.5%	6.8%	5.0%
Other Income	0.11	0.10	0.11	0.13	0.14	0.20	0.18	0.16	0.29	0.31	0.49	3.34
Interest	0.11	0.11	0.07	0.09	0.06	0.08	0.07	0.04	0.03	0.03	0.04	0.00
Depreciation	0.29	0.28	0.23	0.23	0.20	0.20	0.21	0.14	0.14	0.14	0.17	0.20
Profit before tax	0.14	0.10	0.14	0.14	0.17	0.24	0.47	0.61	0.64	0.61	0.68	3.39
Tax %	40.0%	−27.3%	−53.4%	26.7%	27.8%	16.0%	29.2%	23.3%	26.1%	21.0%	24.6%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−0.01	0.00	0.00	0.00	2.28
Net Profit	0.10	0.15	0.24	0.13	0.14	0.22	0.35	0.47	0.50	0.51	0.52	2.83
EPS (Rs)	0.19	0.30	0.49	0.25	0.27	0.45	0.73	1.82	1.94	1.97	2.01	11.02
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Colinz Laboratories balance sheet

₹ crore, at each year end.

Colinz Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.55	3.55	3.55	3.55	3.55	3.55	3.56	3.56	2.53	2.53	2.53	2.53
Reserves	2.63	2.72	2.99	3.22	3.31	3.30	3.76	4.15	5.64	6.45	6.98	7.54
Borrowings	2.52	1.79	0.75	0.41	0.67	0.37	0.99	0.47	0.26	0.56	0.63	0.38
Other Liabilities	1.98	1.71	2.41	2.43	1.66	1.61	1.82	1.77	1.83	1.85	1.71	2.36
Total Liabilities	10.68	9.77	9.70	9.61	9.19	8.83	10.13	9.95	10.26	11.39	11.85	12.81
Fixed Assets	3.15	2.87	2.62	2.40	2.20	2.05	2.02	1.85	1.70	1.57	1.69	1.53
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.30	0.30	0.42	0.54	0.51	0.37	0.62	0.68	0.67	1.03	1.05	1.12
Other Assets	7.23	6.60	6.66	6.67	6.48	6.41	7.49	7.42	7.89	8.79	9.11	10.16
Inventories	2.67	2.23	2.17	1.98	1.91	1.70	1.26	0.94	0.95	0.86	0.79	0.71
Trade receivables	1.36	1.36	1.48	1.69	1.69	1.50	1.31	1.22	1.14	0.87	0.67	0.85
Cash & equivalents	1.79	1.63	1.64	1.88	2.00	2.61	4.70	5.23	5.75	7.03	5.57	8.56
Total Assets	10.68	9.77	9.70	9.61	9.19	8.83	10.13	9.95	10.26	11.39	11.85	12.81

Colinz Laboratories cash flow

₹ crore, for each year.

Colinz Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from operating activity	0.08	0.59	0.05	0.33	0.11	0.57	2.17	0.46	0.41	1.02	−1.44
Cash from investing activity	0.02	0.00	0.00	−0.10	0.00	−0.03	−0.15	−0.02	0.00	0.00	−0.22
Cash from financing activity	0.44	−0.72	−0.02	0.00	0.01	0.05	0.07	0.08	0.10	0.22	0.23
Net cash flow	0.58	−0.17	0.03	0.25	0.13	0.61	2.08	0.53	0.53	1.28	−1.46
Capex	0.00	0.00	0.01	0.00	0.00	0.03	0.15	0.03	0.00	0.00	0.25
Free cash flow	0.08	0.57	0.03	0.33	0.11	0.53	1.99	0.42	0.39	1.02	−1.70
CFO / OP %	26.1%	136.1%	22.1%	106.0%	43.1%	210.0%	659.0%	105.0%	89.1%	224.0%	−252.9%

Colinz Laboratories ratios

Working-capital days and returns, by year.

Colinz Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	63	61	67	78	81	72	77	63	58	45	37	50
Inventory days	289	232	267	266	247	225	208	148	149	134	136	149
Days payable	116	61	56	92	44	49	90	76	103	95	94	81
Cash conversion cycle	235	232	278	253	283	248	195	135	104	84	79	118
Working capital days	111	101	72	74	90	80	0	11	12	−22	74	−60
ROCE %	3.2%	3.2%	3.0%	3.2%	3.4%	3.4%	4.4%	6.8%	8.1%	7.7%	6.7%	7.2%

Colinz Laboratories: frequently asked questions

What are the latest quarterly results of Colinz Laboratories?

For the Jun 2026 quarter, Colinz Laboratories reported sales of ₹1.23 Cr, down 21.2% year on year and net profit of ₹2.41 Cr, up 1,753.8% year on year. The operating margin was 4.9%.

What is the annual revenue of Colinz Laboratories?

Colinz Laboratories' sales for the year to Mar 2026 were ₹6.13 Cr; over the last twelve months they were ₹5.77 Cr.

What is the net profit of Colinz Laboratories?

Net profit for the year to Mar 2026 was ₹0.52 Cr, and ₹2.83 Cr over the last twelve months. Earnings per share over the same trailing period were ₹11.02.

How much debt does Colinz Laboratories have?

Colinz Laboratories reported borrowings of ₹0.38 Cr at Mar 2026, against cash and equivalents of ₹8.56 Cr.

What is the free cash flow of Colinz Laboratories?

Cash from operations was −₹1.44 Cr in the year to Mar 2025; after capital spending, free cash flow was −₹1.70 Cr.

Loading…